Intervention 1: Intervention group: single dose, one oral capsule (IBRANCE® 125 mg, Pfizer Inc. Ireland) as a reference product. after washout period, the volunteers received Palbociclib 125 mg Hard C

2 trials

Sponsors

Abidi Pharmaceutical Company, Actro Middle East Pharmaceutical Co

Conditions

This study is performed on healthy volunteers and drug concentration in plasma is determined..

Phase 1

In-vivo Bioequivalence Study of (IBRACT®, 125 mg Cap., Actero Pharma, Iran)

RecruitingIRCT20200105046010N113

Actro Middle East Pharmaceutical CoThis study is performed on healthy volunteers and drug concentration in plasma is determined..

Start: 2024-08-22Target: 24Updated: 2024-08-26

In-vivo Bioequivalence Study of Palbociclib 125 mg Hard Capsules of The Test Drug (PADENZA®, Abidi Pharma, Iran)

RecruitingIRCT20200105046010N112

Abidi Pharmaceutical CompanyThis study is performed on healthy volunteers and drug concentration in plasma is determined..

Start: 2024-08-22Target: 24Updated: 2024-08-26